Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Clinical Nephrology
You have accessRestricted Access

Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis

Lawrence Copelovitch, Martin A. Nash and Bernard S. Kaplan
CJASN September 2007, 2 (5) 914-918; DOI: https://doi.org/10.2215/CJN.00900207
Lawrence Copelovitch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin A. Nash
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard S. Kaplan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and Objectives: Dent disease is a hereditary form of progressive renal failure characterized by hypercalciuria and proximal tubular dysfunction. The clinical presentation is often insidious with the majority of patients remaining asymptomatic throughout childhood. Despite the seemingly mild, early course, more than 20% of 32 asymptomatic patients in one study had biopsy evidence of focal glomerulosclerosis. Furthermore, end-stage renal disease often occurs in men in early to middle adulthood.

Design, Setting, Participants, & Measurements: This article describes two male patients who presented with asymptomatic proteinuria and were found to have focal glomerulosclerosis. Despite the absence of nephrocalcinosis on renal ultrasound, the diagnosis of Dent disease was considered because of unexplained proteinuria. Subsequent history revealed renal calculi in each maternal family.

Results: The clinical diagnosis of Dent disease was established by intermittent hypercalciuria and low molecular weight proteinuria and confirmed through mutational analysis.

Conclusions: It is hypothesized that a diagnosis of Dent disease may be unrecognized in patients with unexplained proteinuria and idiopathic focal glomerulosclerosis.

Focal segmental glomerulosclerosis (FSGS) is an important cause of proteinuria and nephrotic syndrome in pediatric patients and is now the most frequent cause of nephrotic syndrome in adults (1). There is also substantial risk for progression to ESRD. The histopathologic findings in FSGS can be secondary to systemic conditions that include chronic hypoxemia, reduced nephron mass, HIV infection, and obesity. Similar histopathologic findings are seen in idiopathic (primary) FSGS. These nonspecific histopathologic findings are the reaction of the glomerulus to many types of injury and do not represent a single disease.

In the past 10 yr, studies on the podocyte and its related proteins have added to our understanding of the inherited forms of idiopathic FSGS. Mutations in the Podocin gene, α-Actinin 4 gene, and CD2AP gene cause inherited FSGS (1). These proteins are located in the podocyte foot process and have a critical role in podocyte function, structure, and interactions with the extracellular lipid rafts. Despite these significant advances, the cause of the majority of cases of FSGS remains unknown.

Primary FSGS may also result from undefined circulating factors or cytokines that alter the permeability of the glomerular barrier. Observations that support the hypothesis that there is a circulating factor include the response of some cases of FSGS to medications that suppress lymphocyte function, the recurrence of nephrotic syndrome after renal transplantation, and the injection of serum from patients with FSGS into healthy rats with a resultant nephrotic syndrome (2). Despite numerous attempts, the isolation of these factors has remained elusive.

In addition to the podocyte-related and immunologic-mediated causes of focal sclerosis, several tubulopathies (Dent disease, Gitelman syndrome, Bartter syndrome, and inherited distal renal tubular acidosis) have been associated with focal glomerulosclerosis (3–9). This further suggests that the entity known as focal glomerulosclerosis is not a singular diagnosis but rather a final common pathway resulting from injury that occurs at multiple areas of the nephron. Although systemic conditions, reduced nephron mass, inherited podocytopathies, and immune dysregulation all have been well established as causes of focal sclerosis, we wish to add the primary tubulopathies to the growing list of causes.

In this case report, we review the literature and report two children who had Dent disease and developed significant proteinuria and biopsy-proven focal glomerulosclerosis. We believe that primary tubulopathies, in particular Dent disease, should not be overlooked in the differential diagnosis when considering a patient with idiopathic focal glomerulosclerosis.

Case Reports

Patient 1

A 12-yr-old boy was referred for evaluation of asymptomatic proteinuria detected on a routine sports physical examination. During the preceding two years, he was noted to have orthostatic proteinuria with negative tests on first-morning specimens. The proteinuria was subsequently also present in first-morning samples. The patient did not have edema, gross hematuria, or recent illnesses. Pregnancy and birth were normal and term; however, ABO incompatibility required blood transfusions.

Family History.

A maternal grandfather had a history of renal calculi; he died at 67 yr from glomerulosclerosis, hypertension, and end-stage renal failure that required dialysis. The patient's father received a diagnosis of nerve deafness at 9 yr and wears hearing aids. His mother was diagnosed with a bifurcated uterus and an incompetent cervix.

Physical Examination.

The boy's height was 138.3 cm (fifth to 10th percentile), his weight was 35 kg (10th to 25th percentile), and his BP was 90/50 mmHg. There were no dysmorphic features. He had normal nails and patellae, normal cardiac examination, no rashes, no arthritis, and no periorbital or pedal edema.

Laboratory Studies.

Initial serum concentrations all were normal: Sodium 137 mEq/L, potassium 3.8 mEq/L, chloride 102 mEq/L, carbon dioxide 25 mEq/L, calcium 9.5 mg/dl, phosphorous 3.8 mg/dl, albumin 4.7 g/dl, total cholesterol 201 mg/dl, creatinine 1.0 mg/dl, C3 107 mg/dl, and C4 38 mg/dl. Initial urine protein/creatinine ratio was 1.6 mg/mg. Twenty-four-hour protein excretion was 1283 mg/24 h. Creatinine clearance estimated by the Schwartz formula was 95 ml/min per 1.73 m2. During the subsequent 5 mo, the 24-h protein excretion increased to 1750 mg/24 h. An initial urinalysis during his initial clinic visit showed trace protein, trace blood, no glucose, and no casts. In retrospect, the finding on protein electrophoresis that very little of the total urine protein was albumin and that most of the protein was globulin explained the discrepancy between the finding on standard urinalysis dip sticks that detect only albumin and the measurement of total protein.

Imaging Studies.

A renal ultrasound showed normal-sized kidneys for age and height. The right measured 7.3 cm, and the left measured 8.0 cm. There was normal echotexture and no evidence of a calculus or nephrocalcinosis.

Renal Biopsy.

Thirty-seven glomeruli were present for light microscopy analysis. There were areas of focal global glomerulosclerosis (FGGS). Twenty-five percent (nine of 37) of the glomeruli were globally sclerotic. Perihilar hyalinosis was seen at the vascular pole of one glomerulus. Uninvolved glomeruli were slightly enlarged with minimal segmental increases in mesangial cells. There was slight tubular atrophy and interstitial fibrosis involving <5% of the cortex. Direct immunofluorescent microscopy of the nonsclerotic glomeruli was minimally positive for IgM in the mesangium of several glomeruli. Staining for IgG, IgA, C3, and C1q was negative. Electron microscopy revealed no electron-dense deposits and a normal glomerular basement membrane. The visceral epithelial cells had effacement of 10% of the foot processes.

Course.

Two months after treatment with enalapril, there was moderate reduction in protein excretion to 880 mg/24 h. The family obtained a second opinion, and a diagnosis of Dent disease was considered. The initial spot urine calcium/creatinine ratio was 0.8 (normal <0.2), and the β2-microglobulin excretion was 32,203 μg/L (normal 1 to 160 μg/L). During the past year, the urinary calcium excretion has only been intermittently elevated.

Analysis of the CLCN5 gene showed a duplication of the “A” nucleotide at the 523rd base of the sixth exon (523dupA). The resulting frameshift mutation in the 175th codon (Thr175fsX8) causes a premature stop codon sequence eight residues downstream from the duplication. This analysis was performed by GeneDx (Gaithersburg, MD).

Patient 2

A 9-yr-old boy was referred for evaluation of asymptomatic proteinuria. At 1 yr of age, he had intermittent fevers and hepatosplenomegaly. An extensive metabolic and hematologic evaluation for a cause of the hepatosplenomegaly was negative. The fevers resolved, and during the next 8 yr, he remained asymptomatic. However, the slightly enlarged spleen and liver persisted. At the age of 4 yr, he was evaluated for urinary frequency and dysuria. A urine dipstick showed microscopic hematuria and 300 mg/dl protein. Subsequent studies revealed a normal renal ultrasound, normal serum electrolytes, normal serum creatinine, normal serum albumin, 1321 mg of protein in a 24-h urine collection, and persistent proteinuria in a first-morning sample. At the age of 7 yr, his serum creatinine began to increase to 1.0 mg/dl and, a renal biopsy was performed. Five glomeruli were available for analysis; two were globally sclerotic and three were normal. We first saw the patient for a second opinion 2 mo after his initial renal biopsy. At that time, he did not have edema, gross hematuria, or recent illnesses. We elected to repeat a kidney biopsy.

Family History.

Both maternal grandparents had a history of renal calculi. A maternal aunt had a history of hearing loss. His mother has anticardiolipin antibodies and has had two miscarriages. There is no family history of kidney failure.

Physical Examination.

The boy's height was 129.7 cm (25th percentile), his weight was 27.6 kg (50th percentile), and his BP was 95/62 mmHg. There were no dysmorphic features. He had normal nails and patellae; normal cardiac examination; and no rashes, arthritis, or peripheral edema. The abdomen was soft and nontender. The liver was not enlarged, and the spleen was palpable two finger breadths below the costal margin.

Laboratory Studies.

Initial serum concentrations all were normal: Sodium 141 mEq/L, potassium 3.9 mEq/L, chloride 105 mEq/L, carbon dioxide 25 mEq/L, calcium 9.6 mg/dl, phosphorous 4.4 mg/dl, albumin 4.6 g/dl, and total cholesterol 169 mg/dl. The serum creatinine concentration was 0.9 mg/dl. Creatinine clearance as estimated by the Schwartz formula was 79 ml/min per 1.73 m2.

Imaging Studies.

A renal ultrasound showed normal-sized kidneys for age and height. The right measured 8.0 cm, and the left measured 7.6 cm. There was minimal pelviectasis bilaterally, normal echotexture, and no evidence of calculi or nephrocalcinosis.

Renal Biopsy.

Six glomeruli were evaluated by light microscopy. There were areas of focal global and segmental glomerulosclerosis. Two of the glomeruli were globally sclerotic, two to three glomeruli were segmentally sclerosed in some levels and globally scleroses in others, and one glomerulus was completely normal. Periglomerular fibrosis was seen around one glomerulus. There was patchy, mild interstitial chronic inflammation and proteinaceous casts in some tubules. Other tubules contained granular calcifications. The material examined for immunofluorescence did not contain any glomeruli. Electron microscopy revealed no electron-dense deposits and a uniform capillary basement membrane thickness with some wrinkling in the perimesangial region. The visceral epithelial cells had variable effacement of several of the foot processes.

Course.

The family deferred starting a trial of enalapril. During the past 5 yr, the creatinine has increased to 1.3 mg/dl. Subsequent to the renal biopsy, a diagnosis of Dent disease was considered. The spot urine calcium/creatinine ratio was 0.07 (normal <0.2), the β2-microglobulin excretion was 52,700 μg/L (normal 1 to 160 μg/L), and there was a generalized aminoaciduria.

Analysis of the CLCN5 gene showed a duplication of 3 bp at the 744th bp in the seventh exon (c744_746dupACG). The resulting insertion of an alanine residue at codon 249 is thought to disrupt a highly conserved series of five alanine residues, thereby disrupting a D5 transmembrane domain. This analysis was performed by GeneDx (Gaithersburg, MD).

Discussion

Proximal tubular dysfunction is more common when the nephrotic syndrome is associated with FSGS than with minimal-change nephrotic syndrome (10,11). Furthermore, patients with minimal-change nephrotic syndrome rarely have tubulointerstitial involvement, whereas those with FSGS often have tubulointerstitial infiltration and fibrosis (12). Most investigators have assumed that the nonselective proteinuria in FSGS causes proximal tubular cell injury with the resultant tubulointerstitial damage and scarring. Valles et al. (13) evaluated urinary β2-microglobulin and N-acetyl-β-d-glucosaminidase levels (low molecular weight proteins) in 11 patients with FSGS and found no correlation between the degree of interstitial fibrosis and low molecular weight proteinuria. Consistent with these observations, we challenge the universality of the accepted chronology of events that suggests that nonselective proteinuria in focal sclerosis causes tubulointerstitial damage and fibrosis that causes tubular dysfunction. We propose that in some cases of FSGS, the tubular dysfunction or damage is the primary renal insult and that the glomerulosclerosis may be a secondary epiphenomenon.

In several animal models, high-grade nonselective proteinuria results in proximal tubular swelling, toxicity, and eventual tubulointerstitial inflammation (14,15). It is interesting that none of these models has demonstrated that the end result of these tubular insults is wasting of glucose, amino acids, or electrolytes. The inherited tubulopathies provide a clear example of renal diseases in which the initial damage is tubular but the end result is FSGS. For example, there are a few reports of FSGS associated with Dent disease (3–5), Gitelman syndrome (6,7), Bartter syndrome (8), and inherited distal renal tubular acidosis (9). ESRD can occur between the ages of 25 and 50 yr in patients with Dent disease (16). However, data on the long-term outcomes of patients with Gitelman and Bartter syndromes is scanty but important in regard to our hypothesis. Eighteen patients with Bartter syndrome in the North American Pediatric Renal Cooperative Study database had renal failure. Unfortunately, the specific causes of the renal failure were not available (7). ESRD has also been reported in Gitelman syndrome (17,18), but histologic findings were not included in the reports.

Bouisso et al. (19) described nine children with proximal tubular dysfunction noted 2 to 25 mo after diagnosis of steroid-resistant nephrotic syndrome. There were combinations of glucosuria, hypokalemia, metabolic acidosis, hypophosphatemia, and hypouricemia (19). McVicar et al. (20) reported five cases of childhood nephrotic syndrome associated with renal glycosuria and other tubular defects and suggested that these were early manifestations of FSGS. The proximal tubular defects were noted within the first 3 to 22 mo of diagnosis and at a time when the level of renal function was either normal or slightly depressed (GFR 56 to 90 ml/min per 1.73 m2). All of the children had renal glycosuria as the initial tubular defect, and several also developed aminoaciduria, bicarbonaturia, and phosphaturia. Two of the five patients had near-normal renal function at the time of their initial tubular dysfunction and no evidence of FSGS or interstitial pathology in the initial biopsy specimen. These findings could suggest that a proximal tubular defect preceded the onset of the glomerulosclerosis.

Dent disease is an X-linked renal tubular disorder that is characterized by low molecular weight proteinuria, hypercalciuria, nephrolithiasis, and progressive renal failure. Glucosuria, aminoaciduria, metabolic acidosis, and hypophosphatemia can also occur. X-linked recessive nephrolithiasis, X-linked recessive hypophosphatemic rickets, and the idiopathic low molecular weight proteinuria of Japanese children all are caused by the mutations in the same voltage-gated chloride channel CLCN5 that result in the Dent disease. They are now collectively referred to as Dent disease on the basis of phenotypic similarities and common genetic cause (21). In a study of 32 children who underwent renal biopsy, Murakami et al. (4) found that 22% of asymptomatic Japanese children with idiopathic low molecular weight proteinuria had FGGS. On the basis of the relatively high percentage of patients who had Dent disease and developed focal glomerulosclerosis in the report of Murakami et al. (4) and the frequency of early proximal tubular dysfunction in two case series (19,20), we suggest that Dent disease may not be recognized when it presents as idiopathic focal glomerulosclerosis and perhaps steroid-resistant nephrotic syndrome. This could result in unnecessary treatment with high dosages of corticosteroids and immunosuppressive agents.

Focal sclerotic lesions of glomeruli can be differentiated into two types: FSGS, involving only part of the glomerular tuft, and FGGS, with complete obsolescence in a variable number of glomeruli. FGGS can be seen as part of the normal involution of nephrons. The number of such glomeruli is <10% in 95% of the population under 40 yr of age (22,23). In infants, the presence of an occasional global sclerotic glomerulus may represent an error in nephron formation. In pathologic conditions, such as idiopathic nephrotic syndrome, both focal segmental and global lesions may be seen as part of the progression of focal sclerosis to sclerosis of the entire glomerulus, particularly when associated with tubular atrophy. It has been suggested that children with the nephrotic syndrome and only FGGS without tubular atrophy form a subgroup with a more favorable prognosis, not unlike that of children with minimal-change disease (22,23).

Patients with Dent disease and glomerular abnormalities on renal biopsy usually have FGGS. The tubulointerstitial findings are variable and range from normal to interstitial fibrosis or tubular atrophy (3,4). Because of the irregularity of the sclerotic process, the presence of one or more segmentally sclerotic lesions can occur. Whether FGGS is invariably a separate entity from FSGS or is part of a continuum has yet to be fully determined. Frymoyer et al. (16) described at least one patient who had Dent disease and had renal biopsy findings that showed that 25% of the glomeruli had “partial-to-global sclerosis.” One helpful diagnostic point is that the electron microscopy findings in Dent disease show minimal effacement of the epithelial foot processes, in contrast to FSGS with nephrotic syndrome. We believe that given the lack of convincing evidence in the literature, the diagnosis of Dent disease should be considered in patients with both FGGS and FSGS.

Focal glomerulosclerosis is a nonspecific histologic finding that seems to be the reaction of the glomerulus to a variety of renal insults. Various tubulopathies have been associated with focal glomerulosclerosis. Dent disease is potentially the most important of these causes because it often goes unrecognized as a result of the mild initial clinical features, the absence of overt serum electrolyte abnormalities, and the low incidence (5 to 10%) of glucosuria on routine urinalysis (4). Furthermore, as was noted in our patients, even when the diagnosis is considered, hypercalciuria may not be a constant finding. For reasons that are still unclear, Dent disease may result in ESRD between the ages of 25 and 50 yr. We recommend early consideration of the diagnosis of Dent disease in all cases of unexplained proteinuria and idiopathic focal sclerosis. This can be done initially by screening the urine for excretion of calcium and β2-microglobulin. An accurate diagnosis could prevent needless exposure to potentially hazardous cytotoxic medications in some patients. Furthermore, Cebotaru et al. (24) fed high-citrate diets to ClC-5 knockout mice (a murine model of Dent disease) and significantly delayed progression of renal disease. If these findings translate to human patients, then making the appropriate diagnosis could be important.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • Received February 21, 2007.
  • Accepted May 7, 2007.
  • Copyright © 2007 by the American Society of Nephrology

References

  1. ↵
    Daskalakis N, Winn MP: Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histologic end point. Semin Nephrol26 :89– 94,2005
    OpenUrlCrossRef
  2. ↵
    Benchimol C: Focal segmental glomerulosclerosis: Pathogenesis and treatment. Curr Opin Pediatr15 :171– 180,2003
    OpenUrlCrossRefPubMed
  3. ↵
    Langlois V, Chantale B, Scheinman SJ, Thakker RV, Cox JP, Goodyer PR: Clinical features of X-linked nephrolithiasis in childhood. Pediatr Nephrol12 :625– 629,1998
    OpenUrlCrossRefPubMed
  4. ↵
    Murakami T, Kawakami H: The clinical significance of asymptomatic low molecular weight proteinuria detected on routine screening of children in Japan: A survey of 53 patients. Clin Nephrol33 :12– 19,1990
    OpenUrlPubMed
  5. ↵
    Scheinman SJ: X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int57 :240– 249,1998
    OpenUrlCrossRef
  6. ↵
    Bulucu F, Vural A, Yenicesu M, Caglar K: Association of Gitelman's syndrome and focal glomerulosclerosis. Nephron79 :244 ,1998
    OpenUrlCrossRefPubMed
  7. ↵
    Hanevold C, Mian A, Dalton R: C1q nephropathy in association with Gitelman syndrome: A case report. Pediatr Nephrol21 :1904– 1908,2006
    OpenUrlCrossRefPubMed
  8. ↵
    Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Tracthman H: Bartter syndrome and focal segmental glomerulosclerosis: A possible link between two diseases. Pediatr Nephrol14 :970– 972,2000
    OpenUrlCrossRefPubMed
  9. ↵
    Balgoun RA, Adams ND, Palmisano J, Yamase H, Chughtai I, Kaplan AA: Focal segmental glomerulosclerosis, proteinuria and nephrocalcinosis associated with renal tubular acidosis. Nephrol Dial Transplant17 :308– 310,2002
    OpenUrlCrossRefPubMed
  10. ↵
    Sesso R, Santos AP, Nishida SK, Klag MJ, Carvalhaes JT, Ajzen H, Ramos OL, Pereira AB: Predicition of steroid responsiveness in idiopathic nephrotic syndrome using urinary retinol-binding protein and beta2-microglobulin. Ann Intern Med116 :905– 909,1992
    OpenUrlPubMed
  11. ↵
    Shah V, Taylor GM, Dillon SC: Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome. Pediatr Nephrol12 :643– 647,1998
    OpenUrlCrossRefPubMed
  12. ↵
    Ichikawa I, Fogo A: Focal segmental glomerulosclerosis. Pediatr Nephrol10 :374– 391,1996
    OpenUrlCrossRefPubMed
  13. ↵
    Valles P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W: Follow-up of steroid-resistant nephrotic syndrome: Tubular proteinuria and enzymuria. Pediatr Nephrol15 :252– 258,2000
    OpenUrlCrossRefPubMed
  14. ↵
    Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol5 :1273– 1287,1994
    OpenUrlAbstract
  15. ↵
    Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int51 :2– 15,1997
    OpenUrlCrossRefPubMed
  16. ↵
    Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET: X-linked recessive nephrolithiasis with renal failure. N Engl J Med325 :681– 686,1991
    OpenUrlCrossRefPubMed
  17. ↵
    Bonfante L, Davis PA, Spinello M, Antonello A, D'Angelo A, Semplicini A, Calo L: Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis38 :165– 168,2001
    OpenUrlPubMed
  18. ↵
    Calo LA, Marchini F, Davis PA, Rigotti P, Pagnin E, Semplicini A: Kidney transplant in Gitelman's syndrome. Report of the first case. J Nephrol16 :144– 147,2003
    OpenUrlPubMed
  19. ↵
    Buissou F, Barthe P, Pierragi MT: Severe idiopathic nephrotic syndrome with tubular dysfunction (report of nine cases). Clin Nephrol14 :135– 141,1980
    OpenUrlPubMed
  20. ↵
    McVicar M, Exeni R, Susin M: Nephrotic syndrome and multiple tubular defects in children: An early sign of focal segmental glomerulosclerosis. J Pediatr97 :918– 922,1980
    OpenUrlCrossRefPubMed
  21. ↵
    Igarashi T, Inatomi J, Ohara T, Kuwaha T, Shimadzu M, Thakker RV: Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease. Kidney Int28 :520– 527,2000
    OpenUrl
  22. ↵
    Querfeld U, Waldherr R, Scharer K: The significance of focal global sclerosis in idiopathic nephrotic syndrome. Acta Paediatr Scand74 :913– 919,1985
    OpenUrlPubMed
  23. ↵
    Nash MA, Greifer I, Olbing H, Bernstein J, Bennett B, Spitzer A: The significance of focal sclerotic lesions of glomeruli in children. J Pediatr88 :806– 813,1976
    OpenUrlCrossRefPubMed
  24. ↵
    Cebotaru V, Kaul S, Devuyst O, Cai H, Racusen L, Guggino WB, Guggino SE: High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int68 :642– 652,2005
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology
Vol. 2, Issue 5
September 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
Lawrence Copelovitch, Martin A. Nash, Bernard S. Kaplan
CJASN Sep 2007, 2 (5) 914-918; DOI: 10.2215/CJN.00900207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Hypothesis: Dent Disease Is an Underrecognized Cause of Focal Glomerulosclerosis
Lawrence Copelovitch, Martin A. Nash, Bernard S. Kaplan
CJASN Sep 2007, 2 (5) 914-918; DOI: 10.2215/CJN.00900207
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Case Reports
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Provider Perception of Frailty Is Associated with Dialysis Decision Making in Patients with Advanced CKD
  • Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence
  • Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom
Show more Clinical Nephrology

Cited By...

  • Glomerular Pathology in Dent Disease and Its Association with Kidney Function
  • A Patient with Nephrotic-Range Proteinuria and Focal Global Glomerulosclerosis
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire